KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Capital Expenditures (2021 - 2025)

QuidelOrtho's Capital Expenditures history spans 5 years, with the latest figure at $45.3 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 4.03% year-over-year to $45.3 million; the TTM value through Dec 2025 reached $188.2 million, down 3.54%, while the annual FY2025 figure was $188.2 million, 3.54% down from the prior year.
  • Capital Expenditures for Q4 2025 was $45.3 million at QuidelOrtho, down from $49.2 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $106.9 million in Q4 2021 and bottomed at -$119.5 million in Q1 2023.
  • The 5-year median for Capital Expenditures is $47.2 million (2024), against an average of $40.2 million.
  • The largest annual shift saw Capital Expenditures surged 193.33% in 2023 before it plummeted 31.19% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $106.9 million in 2021, then tumbled by 78.95% to $22.5 million in 2022, then surged by 116.0% to $48.6 million in 2023, then dropped by 2.88% to $47.2 million in 2024, then dropped by 4.03% to $45.3 million in 2025.
  • Per Business Quant, the three most recent readings for QDEL's Capital Expenditures are $45.3 million (Q4 2025), $49.2 million (Q3 2025), and $37.5 million (Q2 2025).